Preliminary clinical evidence suggests certain dietary interventions may improve fatigue and quality of life, but overall reliability of the evidence remains limited.
Immunometabolism (Cobham (Surrey, England) · 5 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Preliminary clinical evidence suggests certain dietary interventions may improve fatigue and quality of life, but overall reliability of the evidence remains limited.
Ultra-processed foods enriched in simple carbohydrates and pro-inflammatory fats are discussed as potentially exacerbating autoimmune sequelae through disruption of the gut microbiome, systemic inflammation, and metabolic dysfunction. Two large prospective cohort studies found no association between diet quality and MS risk. The review highlights that disease-specific dietary recommendations are highly desired by people with MS and suggests therapeutic diets may be customizable to individual preferences, costs, and health status.